BXMEDTECH Get a straight answer
Bx Medtech

Fix what's blocking
revenue growth.

Your product cleared. How are you selling it?

75% of MedTech startups fail before reaching commercial traction.
Of those that make it to market, half see adoption well below expectations.

I find where the system fails and fix it.

Get a straight answer →
Commercial ReadinessMedical DevicesMedTech GTMDigital HealthTechnical TranslationPipeline DevDue DiligenceLife SciencesMedTech InnovatorGTM ArchitectureStartup Advocate Commercial ReadinessMedical DevicesMedTech GTMDigital HealthTechnical TranslationPipeline DevDue DiligenceLife SciencesMedTech InnovatorGTM ArchitectureStartup Advocate
Chelsea Isaac
Chelsea Isaac

I've spent the last 13+ years working in Healthcare and MedTech. My "special sauce" is a combination of high EQ | IQ with strong pattern recognition and a love for making complicated things simple.

Across clinical, regulatory, and commercial, I've seen companies struggle because the systems surrounding their devices and technologies don't appropriately support or translate the value in meaningful ways.

I've built and scaled commercial functions, doubled revenue year over year, and worked with hundreds of early-stage companies through MedTech Innovator.

My passion is helping you identify what works, what doesn't, and where things quietly fail to fix the translation.

Blackbox mascot

Where things start to break

  • You have FDA clearance and a good product. You don't have a commercial system.
  • Your pipeline looks active, but nothing is moving past the second conversation.
  • Your sales team is talking features. Your buyer is asking about outcomes and evidence.
  • You hired a VP of Commercial before you figured out who you're selling to.
This isn't random. It's structural.

Most companies don't need more activity.

They need a system that translates into revenue.

What's built, what's proven, and how it's sold need to align.

What I do

The gap between a cleared product and a commercial business is where I work.
01
Commercial Readiness & Diagnosis
A clear, evidence-based read on what's blocking revenue.
▾

Before you hire a VP of Sales, restructure your pipeline, or overhaul your pricing, you need to know what's broken and what's noise.

I've rebuilt CRM architecture and pipeline reporting from zero. Introduced the data infrastructure that made deal tracking possible. Used that data to figure out where revenue was coming from vs. where the team assumed it was. That discipline is what I bring to your business.

What this looks like
  • Pipeline and CRM forensics
  • ICP validation against actual closed/lost patterns
  • Buyer behavior and pricing alignment
  • Regulatory-to-commercial timeline check
  • Team and process readiness
Output: A prioritized roadmap tied to revenue. What to fix first, what to stop doing, and what the commercial system needs to look like at your stage.
02
Go-to-Market & Commercial Strategy
Define how your product becomes a business.
▾

Selling regulated software is not the same as selling devices. It's not the same as selling SaaS. The pricing logic is different. The sales cycle carries regulatory dependencies most commercial teams aren't built to manage. And the buyer needs a value argument that holds up under procurement scrutiny, not just a product demo.

I've scoped and built commercial strategies for medical device companies across the product lifecycle, from gap analyses to full-build platform engagements. Each required translating regulatory and technical complexity into a commercial path a team could execute.

What this looks like
  • Regulatory-informed commercial timeline (FDA pathway mapped to GTM milestones)
  • ICP definition and buyer segmentation
  • Pricing and packaging strategy
  • Initial sales motion design (who sells, how, to whom, in what order)
  • Commercial readiness gating: what needs to be true before you scale
Output: A clear, executable path from product to revenue. Not a strategy document that sits on a shelf.
03
Technical-Commercial Translation
Make complex products make sense to the people who buy them.
▾

Most MedTech companies can explain what they built. Few can explain why it matters in a way that moves a deal forward. That gap is where revenue stalls.

What this looks like
  • Messaging and positioning that reflects regulatory reality
  • Pitch narratives built from technical substance
  • Value propositions that hold up in procurement
  • Website and collateral clarity
  • Outreach language that reflects how your buyer thinks
Output: Clarity that holds up in the room, whether that's an investor meeting, a hospital procurement review, or a partner negotiation.
04
Commercial Due Diligence & Deal Support
Evaluate whether a MedTech company can convert into revenue.
▾

Most diligence processes look at financials or product in isolation. Nobody's asked whether the commercial motion connecting them is real.

The forensic approach I've applied to pipeline reconstruction and commercial assessment is what due diligence requires: CRM data, deal records, proposals, regulatory filings, and team interviews, pulled into a single clear picture of what's there. I've assessed hundreds of early-stage MedTech companies through MedTech Innovator for commercial viability, team readiness, and path to revenue. That lens is what I bring to investor and acquirer-level evaluation.

What this looks like
  • Pipeline reality vs. perception
  • Commercial readiness scoring across ICP, pricing, sales motion, and evidence maturity
  • Regulatory impact on revenue timelines
  • Competitive positioning assessment
  • Integration risk on the commercial side (post-acquisition)
Output: A decision-grade view of risk, opportunity, and path to revenue. Not a checklist. A narrative that tells you whether this company can get from product to traction, and what's in the way.
2x
Revenue doubled year-over-year
14% → 33%
Deal conversion increase
100+
Early-stage MedTech companies assessed (MedTech Innovator)

Sound familiar?

You have traction, but it's inconsistent
Things are moving, but not predictably.
You're raising, but something feels off
The story isn't fully landing.
You're busy, but not closing
Activity isn't turning into revenue.

How it works

01
We talk
You walk me through what's happening.
02
I give you a read
What's working, what's not, where the opportunity is.
03
We scope it
Clear work. Clear outcomes.
04
I do the work
No handoff. You work directly with me.

What people say

She listens deeply, understands business priorities, and creates alignment between execution, strategy, and growth.
Ben Trombold, MBA
Sales & Marketing Executive · Direct manager
Her knowledge, creativity, friendliness, and work ethic was the bedrock of their commercial success.
Alex Condon
COO, Matrix Connect · Industry collaborator
She is great at understanding a healthcare company's unique needs and developing the perfect strategy for them.
Gira Wieczorek
Investor Relations & Design · Client
One of the smartest, most talented, and hardest-working people I have ever worked with.
Grace Cuillier, MBA, MMB
Director of Business Development · Direct report

Let's find the signal

If something feels off in your commercial motion, it usually is.

Currently onboarding new clients
Get a straight answer →
30-minute call. No pitch. Just clarity.